Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 9;14(5):501.
doi: 10.3390/jpm14050501.

Non-Invasive Retinal Vessel Analysis as a Predictor for Cardiovascular Disease

Raluca Eugenia Iorga  1 , Damiana Costin  2 , Răzvana Sorina Munteanu-Dănulescu  3 , Elena Rezuș  4 , Andreea Dana Moraru  1
Affiliations
Review

Non-Invasive Retinal Vessel Analysis as a Predictor for Cardiovascular Disease

Raluca Eugenia Iorga et al. J Pers Med. .

Abstract

Cardiovascular disease (CVD) is the most frequent cause of death worldwide. The alterations in the microcirculation may predict the cardiovascular mortality. The retinal vasculature can be used as a model to study vascular alterations associated with cardiovascular disease. In order to quantify microvascular changes in a non-invasive way, fundus images can be taken and analysed. The central retinal arteriolar (CRAE), the venular (CRVE) diameter and the arteriolar-to-venular diameter ratio (AVR) can be used as biomarkers to predict the cardiovascular mortality. A narrower CRAE, wider CRVE and a lower AVR have been associated with increased cardiovascular events. Dynamic retinal vessel analysis (DRVA) allows the quantification of retinal changes using digital image sequences in response to visual stimulation with flicker light. This article is not just a review of the current literature, it also aims to discuss the methodological benefits and to identify research gaps. It highlights the potential use of microvascular biomarkers for screening and treatment monitoring of cardiovascular disease. Artificial intelligence (AI), such as Quantitative Analysis of Retinal vessel Topology and size (QUARTZ), and SIVA-deep learning system (SIVA-DLS), seems efficient in extracting information from fundus photographs and has the advantage of increasing diagnosis accuracy and improving patient care by complementing the role of physicians. Retinal vascular imaging using AI may help identify the cardiovascular risk, and is an important tool in primary cardiovascular disease prevention. Further research should explore the potential clinical application of retinal microvascular biomarkers, in order to assess systemic vascular health status, and to predict cardiovascular events.

Keywords: artificial intelligence; cardiovascular disease; retinal microvascular biomarkers; retinal vessel analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart.
Figure 2
Figure 2
Causes and consequences of microvascular dysfunction.
See this image and copyright information in PMC

References

    1. World-Health-Organization . Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. WHO Press; Geneva, Switzerland: 2013.
    1. Strain W.D., Paldánius P.M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc. Diabetol. 2018;17:57. doi: 10.1186/s12933-018-0703-2. - DOI - PMC - PubMed
    1. Cheung C.Y., Ikram M.K., Sabanayagam C., Wong T.Y. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension. 2012;60:1094–1103. doi: 10.1161/HYPERTENSIONAHA.111.189142. - DOI - PubMed
    1. Flammer J., Konieczka K., Bruno R.M., Virdis A., Flammer A.J., Taddei S. The eye and the heart. Eur. Heart J. 2013;34:1270–1278. doi: 10.1093/eurheartj/eht023. - DOI - PMC - PubMed
    1. Streese L., Guerini C., Bühlmayer L., Lona G., Hauser C., Bade S., Deiseroth A., Hanssen H. Physical activity and exercise improve retinal microvascular health as a biomarker of cardiovascular risk: A systematic review. Atherosclerosis. 2020;315:33–42. doi: 10.1016/j.atherosclerosis.2020.09.017. - DOI - PubMed

LinkOut - more resources